Opioïden

PiPTapentadol

Buy Nortilidine

PiPTapentadol – Wholesale PiPTapentadol

PiPTapentadol is a structural analogue of tapentadol featuring a piperidine-type substitution on the phenylpropylamine scaffold. PiPTapentadol is an opioïde analgesic, a Tapentadol derivative with similar effects. This drug acts as an agonist van de μ opioid receptor en a noradrenaline reuptake inhibitor (NRI). This drug is a ontwerper tool for detecting analgesic properties in laboratory conditions.

Prijs:

PiPTapentadol 5 g 100 $ Toevoegen aan winkelwagen

PiPTapentadol 10 g 160 $ Toevoegen aan winkelwagen 

PiPTapentadol 50 g 380 $ Toevoegen aan winkelwagen Gratis verzending!

PiPTapentadol 100 g 600 $ Toevoegen aan winkelwagen Gratis verzending!

PiPTapentadol 500 g 2000 $ Toevoegen aan winkelwagen Gratis verzending

PiPTapentadol 1 kg 3500 $ Toevoegen aan winkelwagen Gratis verzending

 PiPTapentadol – Structural and Pharmacological Overview

Chemical Classification

PiPTapentadol is a synthetic opioid analogue structurally derived from tapentadol, itself a centrally acting analgesic combining μ-opioid receptor agonism with norepinephrine reuptake inhibition (NRI).
In PiPTapentadol, the primary amine group of tapentadol is substituted with a piperidine or piperazine-type moiety, altering its receptor affinity and pharmacokinetic properties.

This modification places PiPTapentadol within the broader arylmethylamine / phenethylamine opioid family, alongside other designer analogues investigated in forensic toxicology and receptor mapping research.

Chemical Features

  • Base structure: Derived from (±)-3-(3-hydroxyphenyl)-N,N-dimethylmethylbutanamine (tapentadol scaffold)
  • Typical substitution: Replacement of the primary amine with piperidine or isopropylpiperidine (PiP) group
  • Functional groups: Phenolic hydroxyl, tertiary amine, secondary alcohol
  • Predicted molecular weight: ~275–310 g/mol (depending on salt form)
  • Likely salt forms: Hydrochloride or fumarate

Pharmacology (Predicted from Structural Analogy)

  1. μ-Opioid Receptor Agonism (MOR):
    The phenolic hydroxyl and basic amine group maintain MOR affinity similar to tapentadol, conferring analgesic and sedative properties in receptor assays.
  2. Norepinephrine Reuptake Inhibition (NRI):
    The extended amine side chain may preserve NRI activity, suggesting a dual mechanism combining opioid and noradrenergic modulation.
  3. Reduced Serotonin Reuptake Affinity:
    Compared to tramadol analogues, PiPTapentadol likely exhibits minimal serotonergic effect.
  4. Expected effects (research observation):
    • Central analgesia (MOR-mediated)
    • Sedation, miosis, respiratory depression (dose-dependent)
    • Elevated norepinephrine tone (mild stimulant-like property at low doses)

Toxicology and Safety Considerations

  • No human pharmacokinetic data are available.
  • As with all novel opioid analogues, PiPTapentadol presents high risk for respiratory depression, CNS depression, and dependence.
  • Cross-tolerance with other opioids is likely but unpredictable.
  • In forensic casework, analogues of tapentadol have been implicated in fatal overdoses when misused.
  • Analytical detection may require LC-MS/MS with specific precursor ion transitions unique to the PiP-substituted moiety.

Forensic and Analytical Use

PiPTapentadol may appear in the context of:

  • Designer opioid screening panels
  • Toxicological reference standard development
  • Structure–activity relationship (SAR) modeling for synthetic analgesics

Legal and Ethical Context

  • Tapentadol is a controlled prescription opioid in most jurisdictions.
  • Its analogues (including PiPTapentadol) are unapproved for medical use and may fall under analogue or NPS control laws.
  • Any handling should comply with local controlled substance regulations and be limited to licensed analytical or academic laboratories.

 Summary

PiPTapentadol is a tapentadol-derived experimental opioid analogue investigated for its unique receptor binding and pharmacological profile. It combines μ-opioid agonism with potential norepinephrine reuptake inhibition, but lacks formal toxicological, safety, or clinical data. Research use is strictly limited to controlled laboratory environments with full compliance to applicable regulations.

PiPTapentadol
PiPTapentadol

 

 

 

 

Synoniemen
  • PiPTapentadol
  • PiPTapentadol HCL
IUPAC    3-(2-methyl-1-(piperidin-1-yl)pentan-3-yl)phenol
Formule    C17H27NO
Molecuulgewicht    261.41 g/mol
CAS
Uiterlijk    A neat solid
Zuiverheid    ≥ 98 %

 

-Kies je favoriete producten uit Chems Axis , en je bent verzekerd van uitstekende kwaliteit tegen de beste prijs.

-Enveloppen worden 24 uur na betaling verzonden.
Levertijd 3-4 werkdagen.
100%-leveringssnelheid in heel Europa.

-U moet op de hoogte zijn van de juridische status van het product dat u in uw land bestelt.
Bij bestelling op onze website vanaf 250 US dollar is de bezorging voor onze rekening. De manager sluit automatisch de verzendkosten uit bij bestellingen vanaf $ 250. 

Beste plek om te kopen PiPTapentadol Online | Where to buy PiPTapentadol

PiPTapentadol is a synthetic opioid analogue structurally derived from tapentadol, itself a centrally acting analgesic combining μ-opioid receptor agonism with norepinephrine reuptake inhibition (NRI). In PiPTapentadol, the primary amine group of tapentadol is substituted with a piperidine or piperazine-type moiety, altering its receptor affinity and pharmacokinetic properties. We are happy to answer your questions or provide more information.

beheerder

Laat een reactie achter

Je e-mailadres wordt niet gepubliceerd. Vereiste velden zijn gemarkeerd met *